BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31249200)

  • 1. Racial disparities in incidence & survival of Kaposi's sarcoma in the United States.
    Kumar V; Soni P; Garg M; Hashmi AT; Chandra AB
    Indian J Med Res; 2019 Mar; 149(3):354-363. PubMed ID: 31249200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
    Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Mukhtar F; Ilozumba M; Utuama O; Cimenler O
    JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Survival of Kaposi's Sarcoma by Race in the United States: A Surveillance, Epidemiology, and End Results Database Analysis.
    Ragi SD; Moseley I; Ouellette S; Rao B
    Clin Cosmet Investig Dermatol; 2022; 15():1681-1685. PubMed ID: 36003526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013.
    Royse KE; El Chaer F; Amirian ES; Hartman C; Krown SE; Uldrick TS; Lee JY; Shepard Z; Chiao EY
    PLoS One; 2017; 12(8):e0182750. PubMed ID: 28829790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men.
    Luu HN; Amirian ES; Chiao EY; Scheurer ME
    Cancer Med; 2014 Dec; 3(6):1635-43. PubMed ID: 25139791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
    Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
    Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
    Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.
    White DL; Oluyomi A; Royse K; Dong Y; Nguyen H; Chang E; Richardson P; Jiao L; Garcia JM; Kramer JR; Thrift AP; Chiao E
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):387-394. PubMed ID: 31242141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality disparities among patients with HIV-associated Kaposi's sarcoma in the southern United States.
    Knights SM; Lazarte SM; Kainthla R; Chiao EY; Nijhawan AE
    AIDS; 2022 Apr; 36(5):721-728. PubMed ID: 34930860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
    Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
    J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for competing risk in patients with AIDS-related Kaposi's sarcoma: A SEER population-based study.
    Wang H; Guo C; Zhang X; Xu Y; Li Y; Wang T; Liu Z; Zhu X; Zhang T
    HIV Med; 2024 Jan; 25(1):60-71. PubMed ID: 37574804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
    Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
    AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men.
    Luu HN; Amirian ES; Scheurer ME
    Br J Cancer; 2013 Mar; 108(5):1173-7. PubMed ID: 23422755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005.
    Armstrong AW; Lam KH; Chase EP
    Epidemiol Infect; 2013 Jan; 141(1):200-6. PubMed ID: 22404880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi Sarcoma Rates Among Persons Living With Human Immunodeficiency Virus in the United States: 2008-2016.
    Luo Q; Satcher Johnson A; Hall HI; Cahoon EK; Shiels M
    Clin Infect Dis; 2021 Oct; 73(7):e2226-e2233. PubMed ID: 33140823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
    Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
    Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.
    Biggar RJ; Horm J; Fraumeni JF; Greene MH; Goedert JJ
    J Natl Cancer Inst; 1984 Jul; 73(1):89-94. PubMed ID: 6588239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The world-wide incidence of Kaposi's sarcoma in the HIV/AIDS era.
    Liu Z; Fang Q; Zuo J; Minhas V; Wood C; Zhang T
    HIV Med; 2018 May; 19(5):355-364. PubMed ID: 29368388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.